Intas Executive and Leadership Team

Rathi Jeetesh, the Chief Executive Officer at Intas, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the research and manufacturing divisions, the Chief Executive Officer ensures that the company maintains a competitive edge in the global pharmaceutical landscape. Rathi Jeetesh drives the expansion of the product portfolio, focusing on high-growth therapeutic areas that address critical patient needs. This leadership role involves constant collaboration with the board to align operational goals with market demands. Through the optimization of internal processes, the Chief Executive Officer fosters a culture of innovation and efficiency. By prioritizing sustainable growth, the executive secures the company's position as a leader in the pharmaceutical sector. Rathi Jeetesh remains dedicated to advancing the mission of providing accessible healthcare solutions to diverse populations across the globe.

Abhimanyu Ojha, the Global Chief Financial Officer & Global President, Finance at Intas, directs the financial strategy and capital allocation for the entire organization. Overseeing global fiscal planning, the Global Chief Financial Officer & Global President, Finance ensures that the company maintains a robust balance sheet to support ongoing research and development initiatives. Abhimanyu Ojha drives financial transparency and risk management across all international operations. This leadership role involves managing investor relations and ensuring compliance with global financial regulations. By analyzing market trends, the executive provides the strategic insights necessary for informed decision-making at the board level. Ojha focuses on optimizing the cost structure to improve profitability while funding critical infrastructure projects. Through the implementation of advanced financial reporting systems, the executive enhances the accuracy and speed of fiscal data analysis. Abhimanyu Ojha secures the financial health required to sustain the company's competitive market position.

Kirti Maheshwari, the Chief Operating Officer at Intas, manages the daily manufacturing operations and supply chain logistics. Overseeing the production facilities, the Chief Operating Officer ensures that all pharmaceutical outputs meet rigorous quality standards and regulatory requirements. Kirti Maheshwari drives operational excellence by implementing advanced manufacturing technologies that increase throughput and reduce waste. This leadership role requires close coordination with the research teams to ensure seamless transitions from development to commercial production. By streamlining the distribution network, the Chief Operating Officer enhances the company's ability to serve international markets efficiently. Maheshwari focuses on scaling production capacity to meet the rising demand for specialized medications. Through the implementation of lean methodologies, the executive optimizes resource allocation across all manufacturing sites. Kirti Maheshwari maintains a sharp focus on operational stability and continuous improvement to support the company's long-term growth objectives.

Vijay Teng, the Global President, Animal Health & Fertility at Intas, directs the development and commercialization of specialized veterinary and fertility products. Overseeing the animal health division, the Global President, Animal Health & Fertility ensures that the company provides high-quality solutions for livestock and companion animals. Vijay Teng drives the expansion of the fertility portfolio by focusing on innovative treatments that address reproductive health needs. This leadership role involves managing global distribution channels to ensure that these specialized products reach diverse markets. By collaborating with research teams, the executive identifies new therapeutic areas for growth within the animal health sector. Teng focuses on maintaining high standards of efficacy and safety for all products in the portfolio. Through the strategic management of these niche divisions, the executive contributes significantly to the company's overall revenue and market impact. Vijay Teng remains committed to advancing veterinary and reproductive medicine through scientific excellence.

Avinash Joshi, the President, Quality at Intas, directs the global quality assurance and regulatory compliance frameworks. Overseeing the quality control laboratories, the President, Quality ensures that every pharmaceutical product meets international safety and efficacy standards. Avinash Joshi drives the implementation of rigorous testing protocols that minimize risk and ensure patient safety. This leadership role involves constant interaction with global regulatory bodies to maintain certifications and market access. By fostering a culture of quality, the executive ensures that all manufacturing processes adhere to the highest industry benchmarks. Joshi focuses on continuous improvement of quality management systems to adapt to evolving global regulations. Through the oversight of compliance audits, the executive protects the company's reputation and operational integrity. Avinash Joshi maintains a focus on excellence in quality, ensuring that the company's products consistently deliver the intended therapeutic benefits to patients worldwide.

Giridhar Venugopal, the President, Emerging Markets & Bd at Intas, directs the business development and expansion strategies in high-growth regions. Overseeing the entry into new territories, the President, Emerging Markets & Bd ensures that the company effectively navigates local market dynamics and regulatory environments. Giridhar Venugopal drives the identification of strategic partnerships and acquisition opportunities that bolster the company's global footprint. This leadership role involves analyzing regional market trends to tailor the product portfolio to local needs. By building strong relationships with local stakeholders, the executive facilitates the successful launch of pharmaceutical products in emerging economies. Venugopal focuses on scaling operations to capture market share in regions with high growth potential. Through the execution of business development initiatives, the executive supports the company's long-term international expansion goals. Giridhar Venugopal remains dedicated to identifying and capitalizing on new market opportunities to drive sustainable growth.

Ajay Tiwari, the President, Human Resources at Intas, directs the global talent management and organizational development strategies. Overseeing the workforce planning, the President, Human Resources ensures that the company attracts and retains top-tier talent to support its research and manufacturing goals. Ajay Tiwari drives the implementation of training and development programs that enhance employee skills and foster a culture of innovation. This leadership role involves managing compensation and benefits structures to remain competitive in the global pharmaceutical market. By promoting diversity and inclusion, the executive builds a high-performing team capable of addressing complex business challenges. Tiwari focuses on aligning human capital strategies with the company's overall mission and operational needs. Through the management of employee relations, the executive ensures a productive and engaged workforce across all global locations. Ajay Tiwari remains committed to building a strong organizational culture that supports the company's long-term success.

C. Yagnik, the President, Legal at Intas, directs the legal strategy and corporate governance frameworks. Overseeing the legal department, the President, Legal ensures that the company operates within the bounds of international law and regulatory requirements. C. Yagnik drives the protection of intellectual property and manages complex litigation to safeguard the company's assets. This leadership role involves providing legal counsel to the board and executive team on strategic initiatives and potential risks. By monitoring changes in global pharmaceutical regulations, the executive ensures that the company remains compliant and prepared for legal challenges. Yagnik focuses on drafting and negotiating contracts that support the company's business development and partnership goals. Through the management of legal affairs, the executive maintains the company's ethical standards and operational integrity. C. Yagnik remains dedicated to providing the legal foundation necessary for the company to pursue its mission of pharmaceutical innovation.

Anshu Verma, the Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) at Intas, directs the external manufacturing partnerships and global marketing strategies. Overseeing the CDMO division, the Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) ensures that third-party collaborations align with the company's quality and production standards. Anshu Verma drives market penetration by developing targeted campaigns that highlight the company's pharmaceutical expertise. This leadership role involves managing complex relationships with global partners to expand the reach of the company's product portfolio. By leveraging market intelligence, the executive identifies new opportunities for contract manufacturing and brand growth. Verma focuses on building strong alliances that enhance the company's service offerings in the pharmaceutical sector. Through the integration of marketing and manufacturing functions, the executive ensures a cohesive approach to market expansion. Anshu Verma maintains a focus on delivering value to clients and patients through strategic external partnerships.

Shivam Mittal, the Executive Vice President & Global Chief Information Officer at Intas, directs the digital transformation and information technology infrastructure. Overseeing the global data systems, the Executive Vice President & Global Chief Information Officer ensures that the company utilizes cutting-edge technology to support research and manufacturing processes. Shivam Mittal drives the implementation of secure cloud solutions and data analytics platforms that improve operational efficiency. This leadership role involves protecting the company's intellectual property through robust cybersecurity measures. By modernizing the IT landscape, the executive enables seamless communication across international offices and production sites. Mittal focuses on integrating artificial intelligence into the drug discovery pipeline to accelerate development timelines. Through the management of digital assets, the executive supports the company's commitment to innovation and technological advancement. Shivam Mittal ensures that the IT strategy remains aligned with the broader business goals of the organization.